Industry News
Pharmaceutical Industry News

Bankruptcy court clears Purdue to fund low-cost opioid rescue medication
Bankruptcy court clears Purdue to fund low-cost opioid rescue medication ntaylor Tue, 03/29/2022 - 06:33
Seeking to shake up eye inflammation market, Optifye and DelSiTech partner on controlled-release drops
Seeking to shake up eye inflammation market, Optifye and DelSiTech partner on controlled-release drops ntaylor Tue, 03/29/2022 - 06:30
Aurobindo strikes branded generics buyout to build biosimilars ‘launch pad’ in India
Aurobindo strikes branded generics buyout to build biosimilars 'launch pad' in India fkansteiner Tue, 03/29/2022 - 06:10
Alopecia Hair Loss: What to Know About Jada Pinkett Smith’s Condition
Jada Pinkett Smith’s hair loss condition played a major role in an incident at the Oscars. Here’s what we know about it.
Bayer CEO Baumann faces revolt from investor Temasek Holdings: report
Bayer CEO Baumann faces revolt from investor Temasek Holdings: report kdunleavy Mon, 03/28/2022 - 11:27
Pfizer and BioNTech go to Hollywood with splashy Oscars sponsorship
Pfizer and BioNTech go to Hollywood with splashy Oscars sponsorship badams Mon, 03/28/2022 - 10:51
‘In the long-term interests:’ FDA oncology chief defends rejection of Lilly, Innovent cancer drug
‘In the long-term interests:’ FDA oncology chief defends rejection of Lilly, Innovent cancer drug aliu Mon, 03/28/2022 - 10:36
FDA halts use of GlaxoSmithKline and Vir’s COVID-19 drug Xevudy in 8 northeast states
FDA halts use of GlaxoSmithKline and Vir's COVID-19 drug Xevudy in 8 northeast states kdunleavy Mon, 03/28/2022 - 09:19
UCB wins wider Fintepla label, setting up showdown with Jazz’s Epidiolex
UCB wins wider Fintepla label, setting up showdown with Jazz's Epidiolex esagonowsky Mon, 03/28/2022 - 08:49
Sanofi rare disease med clinches world-first nod in Japan, presaging potential approvals in US, Europe
Sanofi rare disease med clinches world-first nod in Japan, presaging potential approvals in US, Europe fkansteiner Mon, 03/28/2022 - 08:46
Ten23 health expands former swissfillon facility in Visp, Switzerland
Ten23 health expands former swissfillon facility in Visp, Switzerland jkeenan Mon, 03/28/2022 - 08:41
Biden Administration Plans to Offer Second Booster Shots to Those 50 and Up
After fraught discussions, officials decided that another shot might save thousands of lives if a new coronavirus wave hit before the fall. The F.D.A. could authorize the boosters next week.
AAD 2022: Incyte’s latest Opzelura data show med’s benefit grows over time in vitiligo
AAD 2022: Incyte's latest Opzelura data show med's benefit grows over time in vitiligo fkansteiner Sat, 03/26/2022 - 08:37
HHS is investigating how consumers are marketed accelerated approval drugs
HHS is investigating how consumers are marketed accelerated approval drugs sharon.coey Fri, 03/25/2022 - 12:23
F.D.A. Rushed a Drug for Preterm Births. Did It Put Speed Over Science?
The agency’s accelerated approval program for certain drugs has come under intense scrutiny because some medicines stay on the market despite limited evidence that they work.
Household-name Moderna rolls out a self-aware campaign for Spikevax vaccine
Household-name Moderna rolls out a self-aware campaign for Spikevax vaccine badams Fri, 03/25/2022 - 11:04
Jazz grows cannabinoid manufacturing ambitions with new $100M plant
Jazz grows cannabinoid manufacturing ambitions with new $100M plant fkansteiner Fri, 03/25/2022 - 10:55
Gilead, after 11% revenue increase in 2021, rewards CEO O’Day with $19.2M pay package
Gilead, after 11% revenue increase in 2021, rewards CEO O'Day with $19.2M pay package kdunleavy Fri, 03/25/2022 - 09:42
Gilead, after 11% revenue increase in 2021, rewards CEO Daniel O’Day with $19.2M pay package
Gilead, after 11% revenue increase in 2021, rewards CEO Daniel O'Day with $19.2M pay package kdunleavy Fri, 03/25/2022 - 09:42
Bristol Myers Squibb, Merck hit setback in bid to expand Reblozyl’s anemia nod
Bristol Myers Squibb, Merck hit setback in bid to expand Reblozyl's anemia nod fkansteiner Fri, 03/25/2022 - 08:25


